1. 1. Perez-Lloret S, Flabeau O, Fernagut P, et al. Current concepts in the treatment of multiple system atrophy. Mov Disord Clin Pract 2: 6-16, 2015.
2. 2. Low PA, Reich SG, Jankovic J, et al. Natural history of multiple system atrophy in the USA: a prospective cohort study. Lancet Neurol 14: 710-719, 2015.
3. 3. Wenning GK, Geser F, Krismer F, et al.; European Multiple System Atrophy Study Group. The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 12: 264-274, 2013.
4. 4. Ito H, Kusaka H, Matsumoto S, Imai T. Striatal efferent involvement and its correlation to levodopa efficacy in patients with multiple system atrophy. Neurology 47: 1291-1299, 1996.
5. 5. Ozawa T, Paviour D, Quinn NP, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar system in multiple system atrophy: clinicopathological correlations. 127: 2657-2671, 2004.